Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gastrointestinal Cancers
•
Colorectal Cancer
•
Liver and Pancreas Tumors
•
Internal Medicine
•
Gastroenterology
•
General Hepatology
•
Organ Transplantation
Would you offer HAI (hepatic arterial infusion) or Y90 for colorectal liver metastases as a bridge to transplant?
Related Questions
How would you manage a solitary unresectable liver metastasis?
What is your approach to liver transplantation candidacy in those with decompensated cirrhosis who have been treated for a solid-organ malignancy, such as oral SCC?
How would active Crohn's on Adalimumab affect the adjuvant management of a T2aN0M0 gallbladder cancer?
Would you consider chemo-RT for duodenal adenocarcinoma s/p resection with at least 1 cm positive margin in a patient with a history of Crohn's disease?
Would you offer chemoRT to a colon cancer case with a resected polyp with positive margins if the patient wishes to avoid surgery?
How would you approach the workup of a patient with a history of HCC post-TARE with a recent non-viable MRI but a new portal vein thrombosis?
In a patient with amyloidosis and abnormal liver function but child Pugh A, would you still proceed with SABR for a liver metastasis?
When treating a high rectal cancer, does your coverage of the caudal mesorectum depend on the surgical plan?
How would you workup an elevated IgG level in which there is no evidence of cirrhosis or autoimmune hepatitis on liver biopsy?
In patients with perihilar cholangiocarcinoma eligible for liver transplant, what is the protocol for neoadjuvant chemo-RT, particularly when brachytherapy is not available?
